10-Q Filing

HealthLynked Corp CIK: 1680139 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-037415`
Period End Date	20200930
Filing Date	20201116
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	hlyk-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 112 Cash Flow Statement 110 Stockholders Equity 64

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$44.48K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of September 30, 2020 and December 31, 2019, respectively	`AccountsReceivableNetCurrent`	$83.25K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of September 30, 2020 and December 31, 2019, respectively	`AccountsReceivableNetCurrent`	$193.74K	USD	Point-in-time
Inventory	`InventoryNet`	$105.20K	USD	Point-in-time
Inventory	`InventoryNet`	$70.46K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$119.33K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$80.55K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$794.80K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$817.97K	USD	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$19.20K	USD	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	-	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$5.91K	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$12.06K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.14M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$402.68K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	$777.67K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $817,971 and $794,799 as of September 30, 2020 and December 31, 2019, respectively	`PropertyPlantAndEquipmentNet`	$513.79K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $817,971 and $794,799 as of September 30, 2020 and December 31, 2019, respectively	`PropertyPlantAndEquipmentNet`	$458.67K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $12,064 and $5,908 as of September 30, 2020 and December 31, 2019, respectively	`IntangibleAssetsNetIncludingGoodwill`	$1.34M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill and intangible assets, net of accumulated amortization of $12,064 and $5,908 as of September 30, 2020 and December 31, 2019, respectively	`IntangibleAssetsNetIncludingGoodwill`	$2.59M	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$293.12K	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$314.99K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Assets	`Assets`	$5.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	166.83M	shares	Point-in-time
Total Assets	`Assets`	$2.55M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	109.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	109.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	166.83M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$836.47K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.36M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$51.71K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$105.23K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$201.52K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$493.46K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$743.96K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Government notes payable, current portion	`OtherNotesPayable`	$595.67K	USD	Point-in-time
Government notes payable, current portion	`OtherNotesPayable`	-	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.05M	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.47M	shares	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $777,668 as of September 30, 2020 and December 31, 2019, respectively	`ConvertibleDebtCurrent`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $777,668 as of September 30, 2020 and December 31, 2019, respectively	`ConvertibleDebtCurrent`	$1.54M	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$548.07K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$100.00K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$991.29K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.91M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.12M	USD	Point-in-time
Government notes payable, long term portion	`LongTermNotesAndLoans`	$450.00K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$400.00K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$378.53K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$198.67K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$80.51K	USD	Point-in-time
Total Liabilities	`Liabilities`	$5.14M	USD	Point-in-time
Total Liabilities	`Liabilities`	$5.39M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 166,827,824 and 109,894,490 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$10.99K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 166,827,824 and 109,894,490 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$16.68K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,465,238 and 1,047,904 shares as of September 30, 2020 and December 31, 2019, respectively	`CommonStockIssuableValue`	$159.54K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,465,238 and 1,047,904 shares as of September 30, 2020 and December 31, 2019, respectively	`CommonStockIssuableValue`	$182.09K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$13.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$20.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.86M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$351.82K	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.41M	USD	Point-in-time
Total Liabilities and Shareholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$2.55M	USD	Point-in-time
Total Liabilities and Shareholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$5.50M	USD	Point-in-time

Income Statement 112 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.05M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.85M	USD	3 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.17M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.50M	USD	3 Qtrs
Medicare shared savings revenue	`MedicareSharedSavingRevenues`	-	USD	1 Quarter
Medicare shared savings revenue	`MedicareSharedSavingRevenues`	$767.74K	USD	3 Qtrs
Medicare shared savings revenue	`MedicareSharedSavingRevenues`	-	USD	3 Qtrs
Medicare shared savings revenue	`MedicareSharedSavingRevenues`	$767.74K	USD	1 Quarter
Consulting revenue	`ConsultingRevenue`	$217.60K	USD	1 Quarter
Consulting revenue	`ConsultingRevenue`	-	USD	1 Quarter
Consulting revenue	`ConsultingRevenue`	-	USD	3 Qtrs
Consulting revenue	`ConsultingRevenue`	$268.02K	USD	3 Qtrs
Total revenue	`Revenues`	$2.85M	USD	3 Qtrs
Total revenue	`Revenues`	$4.54M	USD	3 Qtrs
Total revenue	`Revenues`	$1.17M	USD	1 Quarter
Total revenue	`Revenues`	$2.04M	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$590.69K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.76M	USD	3 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.91M	USD	3 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$708.57K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.63M	USD	3 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$521.34K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.29M	USD	3 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$548.67K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	-	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	-	USD	3 Qtrs
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$759.85K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$824.08K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$958.87K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.12M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.08M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$733.36K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$24.98K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.15K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$48.34K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$74.81K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$2.88M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.99M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$6.56M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$5.18M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.34M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-815.69K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-843.08K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.02M	USD	3 Qtrs
Loss on sales of marketable securities	`HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss`	-	USD	3 Qtrs
Loss on sales of marketable securities	`HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Loss on sales of marketable securities	`HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss`	$-281.61K	USD	3 Qtrs
Loss on sales of marketable securities	`HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss`	$-281.61K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$4.90K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-451.00K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-62.46K	USD	3 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-28.89K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-198.76K	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-88.99K	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-79.06K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$12.01K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$133.24K	USD	3 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-841.73K	USD	3 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-530.93K	USD	3 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-362.73K	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-65.82K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$739.49K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$158.69K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$574.21K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$12.80K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$687.00	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$46.00K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	3 Qtrs
Interest expense	`InterestExpenseOther`	$72.53K	USD	1 Quarter
Interest expense	`InterestExpenseOther`	$193.13K	USD	3 Qtrs
Interest expense	`InterestExpenseOther`	$69.56K	USD	1 Quarter
Interest expense	`InterestExpenseOther`	$176.23K	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-1.81M	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-728.44K	USD	3 Qtrs
Total other expenses	`NonoperatingIncomeExpense`	$-309.59K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-891.22K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.07M	USD	3 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.13M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.73M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.83M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.83M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.73M	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$63.86K	USD	3 Qtrs
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$63.86K	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.90M	USD	3 Qtrs
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.07M	USD	3 Qtrs
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.13M	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.80M	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.64M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	147.37M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	129.23M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	96.60M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	147.37M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.64M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.60M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	129.23M	shares	3 Qtrs

Cash Flow Statement 110 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.83M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.73M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$24.98K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.15K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$48.34K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$74.81K	USD	3 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$436.04K	USD	3 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$431.63K	USD	3 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$530.93K	USD	3 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$841.73K	USD	3 Qtrs
Loss on sales of marketable securities	`MarketableSecuritiesUnrealizedGainLosses`	$281.61K	USD	3 Qtrs
Financing cost	`AmortizationOfFinancingCosts`	$12.01K	USD	1 Quarter
Financing cost	`AmortizationOfFinancingCosts`	$133.24K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$739.49K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$574.21K	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$4.90K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-451.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-62.46K	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	3 Qtrs
Change in fair value of debt	`NoncashExpense`	$88.99K	USD	3 Qtrs
Change in fair value of debt	`NoncashExpense`	$198.76K	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$687.00	USD	3 Qtrs
Amortization of lease assets	`AmortizationOfLeaseAssets`	$200.37K	USD	3 Qtrs
Amortization of lease assets	`AmortizationOfLeaseAssets`	$206.49K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.04K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$20.30K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$33.84K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$34.74K	USD	3 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-51.58K	USD	3 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$33.11K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$615.43K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$322.25K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$201.54K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$197.88K	USD	3 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$49.25K	USD	3 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$46.37K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-52.32K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.09M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.73M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleOfMarketableSecurity`	$2.74M	USD	3 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$465.00K	USD	3 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$164.00K	USD	3 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	-	USD	3 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$137.39K	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.54K	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.06K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.43M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-475.06K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.24M	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.10M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$200.00	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$827.50K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.54M	USD	3 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$608.99K	USD	3 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.88M	USD	3 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	-	USD	3 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$149.00K	USD	3 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$967.76K	USD	3 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	3 Qtrs
Proceeds from government loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$1.05M	USD	3 Qtrs
Proceeds from government loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	-	USD	3 Qtrs
Repurchase and retirement of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.20K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$271.31K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.17M	USD	3 Qtrs
Net increase (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.60M	USD	3 Qtrs
Net increase (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-33.37K	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$135.78K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$102.41K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.71M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$135.78K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$102.41K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.71M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$202.77K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$23.57K	USD	3 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	3 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$1.28M	USD	3 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$211.50K	USD	3 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$35.00	USD	3 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	3 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$54.26K	USD	3 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.67M	USD	3 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$737.65K	USD	3 Qtrs
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	-	USD	3 Qtrs
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	$24.12K	USD	3 Qtrs
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	-	USD	3 Qtrs
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	$221.00	USD	3 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$560.05K	USD	3 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$219.74K	USD	3 Qtrs
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$201.68K	USD	3 Qtrs
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$1.00M	USD	3 Qtrs
Fair value of contingent acquisition consideration liability recorded at acquisition date	`FairValueOfContingentAcquisitionConsiderationIssued`	$1.06M	USD	3 Qtrs
Fair value of contingent acquisition consideration liability recorded at acquisition date	`FairValueOfContingentAcquisitionConsiderationIssued`	$500.00K	USD	3 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$328.00K	USD	3 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$390.43K	USD	3 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$135.30K	USD	3 Qtrs
Fair value of shares issued as contingent acquisition consideration	`FairValueOfSharesIssuedAsContingentAcquisitionConsideration`	$292.78K	USD	3 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	-	USD	3 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	$200.33K	USD	3 Qtrs
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceivedAsConsiderationForSaleOfCommonAndPreferredSh`	$3.01M	USD	3 Qtrs
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	-	USD	3 Qtrs
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	$225.32K	USD	3 Qtrs
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtsAllocatedToAdditionalPaidInCapital`	$283.86K	USD	3 Qtrs

Stockholders Equity 64 line items

Line Item	Tag	Value	Unit	Period
Balance at	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Balance at	`StockholdersEquity`	$351.82K	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.41M	USD	Point-in-time
Acquisition of Hughes Center for Functional Medicine	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	1 Quarter
Fair value of warrants allocated to proceeds of convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$225.32K	USD	1 Quarter
Acquisition of Cura Health Management LLC	`AcquisitionOfCuraHealthManagementLLC`	$201.68K	USD	1 Quarter
Contingent acquisition consideration issued	`ContingentAcquisitionConsiderationIssued`	$292.78K	USD	1 Quarter
Sale of common and preferred stock in exchange for marketable securities	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$3.07M	USD	1 Quarter
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtAllocatedToAdditionalPaidInCapital`	$283.86K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$145.46K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$317.16K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$694.16K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$348.60K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$246.34K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$253.78K	USD	1 Quarter
Repurchase of treasury stock	`RepurchaseOfTreasuryStock`	$-1.20K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$15.58K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$139.07K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$33.48K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$88.83K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$57.44K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$12.50K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$6.94K	USD	1 Quarter
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$4.68K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	-	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$54.26K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$533.28K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$652.56K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$63.66K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$138.76K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$479.67K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$535.23K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$64.35K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$66.99K	USD	1 Quarter
Consultant fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$26.84K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$129.76K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$43.70K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`StockToBeIssuedForConsultantFeesShares`	$66.88K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$38.58K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$39.41K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$59.40K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$34.55K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$98.50K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$61.23K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$200.00	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.73M	USD	1 Quarter
Net loss	`ProfitLoss`	$-879.57K	USD	1 Quarter
Net loss	`ProfitLoss`	$-580.22K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.06M	USD	1 Quarter
Balance at	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Balance at	`StockholdersEquity`	$351.82K	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.48M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance at	`StockholdersEquity`	$-2.41M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.